KHOO TECK PUAT HOSPITAL

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Established: 2010-01-01

Employees: -

Market Cap: -

Website: https://www.ktph.com.sg/main/home

Clinical Trials

Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study

Phase 4

Completed

Conditions: Diabetes

Interventions: Drug: Gliclazide
Drug: Glibenclamide

First Posted Date: 2014-07-28

Last Posted Date: 2016-09-01

Lead Sponsor: Khoo Teck Puat Hospital

Target Recruit Count: 8

Registration Number: NCT02201602

Locations: 🇸🇬
Khoo Teck Puat Hospital, Singapore, Singapore

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Phase 4

Completed

Conditions: Type II Diabetes in Subjects BMI 27 to 32

Interventions: Procedure: Roux-en-Y Gastric Bypass (RYGB)
Drug: Incretin analogues
Drug: Xenical
Drug: SGLT2 inhibitors
Drug: DPP-4 Inhibitors

First Posted Date: 2014-01-22

Last Posted Date: 2022-06-23

Lead Sponsor: Khoo Teck Puat Hospital

Target Recruit Count: 40

Registration Number: NCT02041234

Locations: 🇸🇬
Khoo Teck Puat Hospital, Singapore, Singapore

Effects of Resveratrol in Patients With Type 2 Diabetes

Phase 1

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Trans-resveratrol extract from Polygonum Cuspidatum
Drug: Placebo

First Posted Date: 2012-09-03

Last Posted Date: 2012-09-03

Lead Sponsor: Khoo Teck Puat Hospital

Target Recruit Count: 10

Registration Number: NCT01677611

Locations: 🇸🇬
Alexandra Health, Khoo Teck Puat Hospital, Singapore, Singapore

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy